As Peter Lynch said "buy companies that are hated by public"
Touched the bottom of downward channel. Upcoming PDUFA can affect the stock price in a negative way and push it to $1 (or even down below a bit).
The company has a huge debt and it is priced as BK company but it has great pipeline and it has all the chances to get a decent deal on opioid case. In such a case it will skyrocket. The issues are the same as they were when the stock price was $80. In case if opioid deal settled company capitalization will be 10 times higher at least. Drivers for further revenue growth: Terlipressin, Stratagraft, iNO. For now, valuation of the company is ridiculous.
Be aware it is very high risk game. Kind of binary game.